Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration.

چکیده

Treatment decisions for neovascular age-related macular degeneration (nAMD) in the setting of individualised treatment regimens are adapted to disease activity. The main marker of disease activity and trigger for re-treatment with anti-vascular endothelial growth factor (anti-VEGF) agents is the…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط